Factors predicting success or failure associated with common types of transplants

被引:1
作者
Bolwell, BJ
机构
[1] Cleveland Clin Fdn, Dept Hematol & Med Oncol, Taussig Canc Ctr, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Transplant Ctr, Cleveland, OH 44195 USA
关键词
hematopoietic stem cell transplant; predictive factors; cellular graft components;
D O I
10.1111/j.1399-3046.2005.00443.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The ability to predict clinical outcomes is essential to accurate medical decision analysis. Many accepted bone marrow transplant related prognostic variables are derived from data that is over 20-years old and may or may not be applicable to current medical practice. This report reviews both older data concerning bone marrow transplantation prognostic factors as well as more current reports. In addition to pre-transplant variables, this review examines easily measured post-transplant variables that may affect prognosis, as well as data concerning the cellular component of the infused graft in both allogeneic and autologous transplantation.
引用
收藏
页码:2 / 11
页数:10
相关论文
共 92 条
[1]  
ATKINSON K, 1990, BLOOD, V75, P2459
[2]  
BACIGALUPO A, 1993, BONE MARROW TRANSPL, V12, P443
[3]  
Bacigalupo A, 1998, EXP HEMATOL, V26, P409
[4]   Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin [J].
Bacigalupo, A ;
Oneto, R ;
Bruno, B ;
Soracco, M ;
Lamparelli, T ;
Gualandi, F ;
Occhini, D ;
Raiola, AM ;
Mordini, N ;
Berisso, G ;
Bregante, S ;
Dini, G ;
Lombardi, A ;
Van Lint, MT ;
Brand, R .
BONE MARROW TRANSPLANTATION, 1999, 24 (06) :653-659
[5]   FAVORABLE OUTCOME OF PATIENTS OLDER THAN 40 YEARS OF AGE AFTER TRANSPLANTATION WITH MARROW GRAFTS DEPLETED OF LYMPHOCYTES BY COUNTERFLOW CENTRIFUGATION [J].
BAR, BMAM ;
DEWITTE, T ;
SCHATTENBERG, A ;
BOEZEMAN, J ;
HOOGENHOUT, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (01) :53-60
[6]  
BARRETT AJ, 1989, BLOOD, V74, P862
[7]  
BEARMAN SI, 1990, BONE MARROW TRANSPL, V5, P173
[8]   Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation [J].
Bittencourt, H ;
Rocha, V ;
Chevret, S ;
Socié, G ;
Espérou, H ;
Devergie, A ;
Dal Cortivo, L ;
Marolleau, JP ;
Garnier, F ;
Ribaud, P ;
Gluckman, E .
BLOOD, 2002, 99 (08) :2726-2733
[9]   Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors [J].
Blaise, D ;
Bay, JO ;
Faucher, C ;
Michallet, M ;
Boiron, JM ;
Choufi, B ;
Cahn, JY ;
Gratecos, N ;
Sotto, JJ ;
François, S ;
Fleury, J ;
Mohty, M ;
Chabannon, C ;
Bilger, K ;
Gravis, G ;
Viret, F ;
Braud, AC ;
Bardou, VJ ;
Maraninchi, D ;
Viens, P .
BLOOD, 2004, 103 (02) :435-441
[10]   Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant [J].
Bolwell, B ;
Pohlman, B ;
Sobecks, R ;
Andresen, S ;
Brown, S ;
Rybicki, L ;
Wentling, V ;
Kalaycio, M .
BONE MARROW TRANSPLANTATION, 2004, 33 (04) :419-423